Is SKWD a Good Stock to Buy? The Bull and Bear Case (2026)

Last updated November 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for Skyward Specialty Insurance (SKWD) rests on Apollo turns an underwriter into a fee earner as well: Apollo Syndicate Management runs nine Lloyd's syndicates, only some of which Skyward capitalises. The bear case rests on the largest exposure is reserve adequacy. Analysts covering it publish targets from $56.00 to $80.00 against a $64.43 share price on November 20, 2026, so even the professionals disagree by 34% of their own average. We do not give a verdict. Each case is set out below at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

SKWD key stats

At $64.43 on November 20, 2026, Skyward Specialty Insurance (SKWD) has a market cap of $2.9B and a P/E of 15.0 on trailing earnings (11.5 on forward earnings).

Market cap
$2.9B
P/E (trailing)
15.0
P/E (forward)
11.5
EPS (trailing 12 months)
$4.30
Price to book
2.2
Beta
0.31

Market cap, P/E and yield are measured at the $64.43 price on November 20, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.

What's new with Skyward Specialty Insurance (SKWD)?

The last two weeks for Skyward Specialty Insurance, as of November 22, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.

  • SKWD closed at $64.43 on November 20, 2026, up 2.2% over the past five trading days (from $63.02).
  • On November 16, 2026, TD Cowen raised its target to $69.00 from $65.00 (Hold).

Skyward Specialty Insurance filed no current, quarterly or annual report with the SEC in the last two weeks.

Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.

Skyward writes commercial property and casualty insurance in niches most carriers do not staff for. The US business is organised into nine underwriting divisions, each with dedicated leadership: Accident & Health, Captives, Credit & Surety, Energy Solutions, Global Agriculture, Global Property, Professional Lines, Specialty Programs and Transactional E&S. Second-quarter 2026 gross written premiums from those divisions came to ~$667.9M, up 14.1% year over year, with Global Agriculture nearly doubling to ~$111.9M and Accident & Health up 57.8% to ~$95.5M, while Captives, Energy Solutions and Global Property each contracted by mid-teens percentages. Management calls the approach "Rule Our Niche", and the intended consequence is that close to half the book sits in lines that do not track the property catastrophe cycle. On January 1, 2026 the company closed a ~$559.1M purchase of Apollo Group Holdings, paid for with ~$371.1M of cash and 3,679,332 Skyward shares valued at $51.11 each. Apollo underwrites through Syndicates 1969 and 1971 with its own capital and provides managing agency services to nine Lloyd's syndicates in total, which hands Skyward a fee stream on premium it does not carry: ~$318.1M of fee-generating gross written premium in the quarter. Underwriting margin, not premium volume, is what moves the earnings. Skyward posted an 89.5% combined ratio in the second quarter of 2026 and 89.3% for full-year 2025, keeping roughly ten cents of underwriting profit on every premium dollar before any investment return. Net investment income of ~$30.7M in the quarter, up ~$12.0M year over year on a ~$2.74B portfolio, is the second leg. Together they produced ~$59.2M of operating income in the quarter, ~$1.30 per diluted share, a 46% increase, and a 19.0% annualized operating return on equity. The market is paying ~$65.44 per share for that at the November 20, 2026 close, about 2.3x book value on Yahoo's figures and roughly 3.4x the $19.41 June tangible book per share. Trailing GAAP earnings of ~$4.30 per share put the stock near 15x, and the ~$5.61 analysts expect for 2027 brings that to about 11.7x. The shares are up ~34.6% year to date and ~40.4% over one year, including ~8.4% in the past month. Two line items now sit between operating and reported earnings: ~$8.8M of quarterly intangible amortization against ~$0.4M a year earlier, and interest expense of ~$8.8M against ~$1.9M, on the ~$437M of debt outstanding after funding Apollo. Underwriting income of ~$54.8M in the quarter, against ~$31.2M a year earlier, shows where the operating gain came from. Since the second-quarter report the news has been about distribution and claims, and then the third quarter. On September 22, 2026 Skyward announced a claims-payment partnership using a digital payments product called ClaimsSnap, and on September 30 it said it was expanding ibott's autonomous-vehicle insurance solutions into the US primary market. Third-quarter results on November 5, 2026 showed ~$455.3M of revenue, up ~19% year over year but ~10% below the ~$507M consensus, as net earned premium of ~$406.9M (up ~15.7%) came in under the ~$454M analysts expected. StockStory attributed the shortfall to headwinds in agriculture, offset partly by fee income and Accident & Health. Underwriting held up: the combined ratio was 89.9% (61.7% loss, 28.2% expense), against a 90.9% estimate, and EPS of ~$1.28 beat the ~$1.22 consensus and the ~$1.05 of a year earlier. Net income was ~$49.8M for the quarter and ~$148.6M for nine months. That makes five straight quarterly EPS beats. Separately, Slingshot Insurance named Skyward its primary carrier partner across all 50 states, and Skyward co-led Slingshot's ~$27M seed round. Analysts expect ~$1.28 of EPS on ~$496M of revenue for the fourth quarter.

The bull case: what would have to be true for $80.00

The most optimistic published target on SKWD is $80.00, +24.2% from the $64.43 share price on November 20, 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

1. Apollo turns an underwriter into a fee earner as well

Apollo Syndicate Management runs nine Lloyd's syndicates, only some of which Skyward capitalises. Aligned syndicates (1969, 1971 and the reinsurance vehicle 1972) generated ~$217.2M of fee-generating gross written premium in the second quarter, and third-party partner syndicates added ~$100.9M, up 82.0% year over year after a new partner joined the platform. Total managed premiums reached ~$1,058.7M in the quarter against ~$740.6M of gross written premium the group actually underwrites, so roughly 30% of the premium flowing across the platform earns commission and profit-share rather than underwriting risk. Underwriting fee income of ~$12.6M in the quarter carried ~$4.6M of direct expense against it. Profit commissions on syndicate results are generally not payable until the underlying underwriting year has substantially matured, typically around 36 months from inception, so the fee stream lags the premium it is earned on. In the third quarter, underwriting fee income was ~$11.0M against a ~$13.2M estimate, while commission and fee income rose ~63.8% to ~$3.1M. The Slingshot arrangement announced in November, where Skyward is the primary carrier across all 50 states and co-led a ~$27M seed round, extends the same partner-distribution approach to the US side.

2. Nine divisions that grow and shrink on their own schedules

The point of the division structure is that Skyward can shrink a line into a soft market without shrinking the company. In the second quarter of 2026 Global Agriculture grew 95.8% to ~$111.9M and Specialty Programs grew 29.7% to ~$111.4M, while Global Property fell 15.3%, Energy Solutions fell 16.2% and Captives fell 16.6%. Total continuing-business premium still rose 14.1%. Management restructured the reporting in the first quarter of 2026, folding Credit into Surety, renaming Agriculture and Credit (Re)insurance as Global Agriculture, and dropping Construction from what is now Energy Solutions, with prior periods conformed. The mix shift has a visible cost in the loss ratio: the Skyward Specialty segment's loss and loss-adjustment ratio rose 1.3 points in the quarter, attributed to growth in accident & health and global agriculture, offset by a 2.7-point improvement in that segment's expense ratio. New niches keep being added at the edges: in late September 2026 Skyward said it was taking ibott's autonomous-vehicle insurance products into the US primary market, a small line today but the kind of specialised risk the division model is built to absorb. The third-quarter revenue miss came largely from agriculture, the same division that had nearly doubled in the second quarter, which shows how much a single niche can swing the total.

3. Reserve development has stayed clean through the growth

Rapid premium growth in casualty lines is where reserve error usually surfaces, so the development line is the one to track. For the six months ended June 30, 2026, incurred losses related to prior years were nil on a net basis, the same as the comparable 2025 period. Full-year 2025 carried 0.6 points of favorable prior-accident-year development. Full-year 2024 was the outlier at 1.1 points adverse, including 4.2 points in the fourth quarter alone, which the company attributed to the net impact of a loss portfolio transfer covering older accident years. Net reserves for losses and loss adjustment expenses stood at ~$1,908.1M at June 30, 2026 against ~$3,070.6M gross, with ~$1,162.5M of reinsurance recoverable on unpaid claims sitting between the two.

4. Capital return has started from a small base

Skyward pays no dividend and has repurchased sparingly. The board authorised $50M in October 2024 and doubled it to $100M on July 15, 2026. During the second quarter of 2026 the company bought 223 thousand shares for ~$9.7M, an average near $43.50, and treasury stock stood at 431,006 shares carried at ~$19.4M at quarter end. The company also repaid $50.0M of the Tranche A delayed-draw term loan on June 26, 2026, leaving ~$417.6M of notes payable plus ~$19.6M of subordinated debt against ~$1,267.5M of equity. Skyward Specialty's US insurance subsidiaries hold an 'A' (Excellent) financial strength rating from AM Best, affirmed with a stable outlook on August 14, 2025, and the credit facilities carry a minimum AM Best rating covenant.

The bear case: what would have to be true for $56.00

The most pessimistic published target is $56.00, -13.1% from the current price. It is neither a floor nor a forecast; it is roughly what one analyst thinks Skyward Specialty Insurance is worth if the risks below bite instead of the drivers above.

The largest exposure is reserve adequacy. Net loss reserves of ~$1,908.1M exceed shareholders' equity of ~$1,267.5M by half again, so a 5% deficiency across the book would consume roughly 7% of book value before tax. Growth compounds that: Global Agriculture premium nearly doubled year over year and Accident & Health rose 57.8%, and immature accident years in fast-growing lines are where estimation error tends to appear two or three years later. A second, less discussed exposure is credit. Reinsurance recoverables of ~$1,411.6M are larger than the entire equity base, and Skyward remains liable to policyholders if a reinsurer fails to pay. The company has also been retaining more risk itself, with net retention on a written basis rising to 65.6% in the second quarter of 2026 from 58.0% a year earlier, which raises the loss volatility that reaches the income statement. Apollo brings its own set. Goodwill and intangibles of ~$471.2M now equal ~37% of equity, including $200M of indefinite-lived syndicate capacity that is tested for impairment rather than amortised, and the 10-Q states that the assessment of internal control over financial reporting excludes Apollo while integration continues. The Lloyd's segment ran a 97.6% combined ratio in the quarter with 5.4 points of catastrophe loss attributed primarily to the conflict in the Middle East, a reminder that the acquired book carries political and war exposure the US divisions largely do not. Pricing is the background condition: management's own 2026 guidance assumes a 90.5% to 91.5% combined ratio, above the 89.5% delivered in the first half, which implies an expected second-half deterioration. Alternative and strategic investments have been a persistent drag, costing ~$8.1M in the first half of 2026 after ~$11.5M in 2025. Chief Financial Officer Mark Haushill is retiring effective March 31, 2027. Top-line growth is also less steady than the earnings beats suggest: third-quarter revenue of ~$455.3M was ~10% below consensus and below the ~$489.5M of the second quarter, and Zacks has questioned whether profit growth can continue while net premiums decline. Finally, the share price now carries more expectation than in the summer: at ~$65.44 on November 20, 2026 the stock sits at the top of its ~$40.60 to ~$65.88 52-week range after a ~34.6% gain this year, so a reserve surprise or a further revenue shortfall would land on a fuller multiple.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding SKWD already, these risks exist either way; what to check is whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on SKWD

11 analysts cover SKWD, with an average target of $71.45 (+10.9% against $64.43) and a split of 9 buy, 4 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the SKWD forecast and price target page.

How is SKWD valued?

Market cap, P/E and dividend yield at today's price are in the SKWD key stats above. The business figures below come from Skyward Specialty Insurance's reported results as of November 2026 and change when it next reports.

  • Revenue (TTM): ~$1.81B for the twelve months to September 30, 2026, up ~19% year over year in the latest quarter, against ~$1.42B in fiscal 2025, ~$1.15B in 2024 and ~$886M in 2023. Quarterly revenue ran ~$475.9M, ~$489.5M and ~$455.3M across the first three quarters of 2026, with Apollo included from January 1.
  • Margins: Operating margin ~15.7% and net profit margin ~10.6% on a trailing basis. For an insurer the combined ratio carries more information: 89.9% in the third quarter of 2026 (61.7% loss, 28.2% expense), 89.5% in the second, 89.3% for full-year 2025 and 92.3% for 2024.
  • Net income and EPS: Trailing net income ~$191.8M and EPS ~$4.30. Third-quarter 2026 net income ~$49.8M with EPS of ~$1.28 against a ~$1.22 consensus and ~$1.05 a year earlier; nine-month net income ~$148.6M. Full-year 2025 net income was ~$170.0M.
  • Book value: ~2.3x book on Yahoo's figures. Book value per share was $28.55 at June 30, 2026, up 14.6% in six months, and tangible book roughly $19.41 per share after ~$471.2M of goodwill and intangibles.
  • Balance sheet: ~$719M of cash and ~$437M of debt (debt to equity ~34%) at September 30, 2026. Debt rose to fund the Apollo purchase and was cut by a $50.0M term loan repayment in June.
  • Market value and dividend: ~$2.91B at the ~$65.44 close of November 20, 2026, near the top of a ~$40.60 to ~$65.88 52-week range; up ~34.6% year to date and ~40.4% over one year. No dividend. Eleven analysts on Yahoo average a Buy rating with a mean target near ~$71.45.

As of November 2026: A screener's ~1.6x price-to-sales figure carries almost no signal for SKWD, because insurance revenue is premium the company has already promised to pay claims against. The multiples that carry information are price to book, ~2.3x in November 2026, and forward earnings, ~11.7x, which sit below the levels the market has awarded the fastest-growing US excess and surplus underwriters and above carriers whose returns hover near their cost of capital. On tangible book the multiple is closer to 3.4x, since ~$471.2M of the equity base is goodwill and intangibles from Apollo.

How do you decide if SKWD is a buy?

Whether SKWD is a buy is easier to judge through four narrower questions:

  • Thesis: do you believe the bull case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold SKWD indirectly through an index or sector ETF before adding more.

What would change your mind on SKWD

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

  • Bull case breaks if: Apollo turns an underwriter into a fee earner as well stalls in the reported numbers. A shift in the narrative around them is not enough on its own.
  • Bear case breaks if: the largest exposure is reserve adequacy fails to materialise over several reporting periods while the drivers keep compounding.
  • Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the SKWD stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about SKWD against your real portfolio and see your actual exposure before deciding.

Your questions about Skyward Specialty Insurance

Ask Walnut's AI anything about SKWD and see how it fits what you own.

FAQ

Is SKWD a good stock to buy right now?

+

That depends on which case you find more convincing, and both are on this page. The bull case rests on Apollo turns an underwriter into a fee earner as well, with revenue (ttm) at ~$1.81B for the twelve months to September 30, 2026, up ~19% year over year in the latest quarter, against ~$1.42B in fiscal 2025, ~$1.15B in 2024 and ~$886M in 2023. Quarterly revenue ran ~$475.9M, ~$489.5M and ~$455.3M across the first three quarters of 2026, with Apollo included from January 1.. The bear case rests on the largest exposure is reserve adequacy. Analysts covering it are spread from $56.00 to $80.00, a spread wide enough to show the question is contested. If you believe the thesis, the questions that matter next are sizing and overlap; timing comes after. Walnut is not an investment adviser and this is not a recommendation.

Should I sell SKWD?

+

Nobody can answer that for you, and a more useful version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The largest exposure is reserve adequacy. If that risk is what you were worried about and it is now playing out, take it seriously. If the price simply fell while the thesis held, the situation is different. The most pessimistic published target is $56.00, -13.1% from the $64.43 price, which is one analyst's downside case. It is not a floor. Walnut is not an investment adviser.

What is the bull case for SKWD?

+

Apollo turns an underwriter into a fee earner as well. Apollo Syndicate Management runs nine Lloyd's syndicates, only some of which Skyward capitalises. The most optimistic analyst target on SKWD is $80.00, +24.2% from the $64.43 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for SKWD?

+

The largest exposure is reserve adequacy. Net loss reserves of ~$1,908.1M exceed shareholders' equity of ~$1,267.5M by half again, so a 5% deficiency across the book would consume roughly 7% of book value before tax. Growth compounds that: Global Agriculture premium nearly doubled year over year and Accident & Health rose 57.8%, and immature accident years in fast-growing lines are where estimation error tends to appear two or three years later. A second, less discussed exposure is credit. Reinsurance recoverables of ~$1,411.6M are larger than the entire equity base, and Skyward remains liable to policyholders if a reinsurer fails to pay. The company has also been retaining more risk itself, with net retention on a written basis rising to 65.6% in the second quarter of 2026 from 58.0% a year earlier, which raises the loss volatility that reaches the income statement. Apollo brings its own set. Goodwill and intangibles of ~$471.2M now equal ~37% of equity, including $200M of indefinite-lived syndicate capacity that is tested for impairment rather than amortised, and the 10-Q states that the assessment of internal control over financial reporting excludes Apollo while integration continues. The Lloyd's segment ran a 97.6% combined ratio in the quarter with 5.4 points of catastrophe loss attributed primarily to the conflict in the Middle East, a reminder that the acquired book carries political and war exposure the US divisions largely do not. Pricing is the background condition: management's own 2026 guidance assumes a 90.5% to 91.5% combined ratio, above the 89.5% delivered in the first half, which implies an expected second-half deterioration. Alternative and strategic investments have been a persistent drag, costing ~$8.1M in the first half of 2026 after ~$11.5M in 2025. Chief Financial Officer Mark Haushill is retiring effective March 31, 2027. Top-line growth is also less steady than the earnings beats suggest: third-quarter revenue of ~$455.3M was ~10% below consensus and below the ~$489.5M of the second quarter, and Zacks has questioned whether profit growth can continue while net premiums decline. Finally, the share price now carries more expectation than in the summer: at ~$65.44 on November 20, 2026 the stock sits at the top of its ~$40.60 to ~$65.88 52-week range after a ~34.6% gain this year, so a reserve surprise or a further revenue shortfall would land on a fuller multiple. The most pessimistic published target is $56.00, -13.1% from the current price, which is roughly what one analyst thinks the stock is worth if these risks bite and the drivers do not.

What does Skyward Specialty Insurance do?

+

Skyward Specialty writes commercial property and casualty insurance in niches most carriers do not staff for, and is judged on its combined ratio.

What would have to change for SKWD to stop being worth holding?

+

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Apollo turns an underwriter into a fee earner as well) stalling in the reported numbers (a change in the narrative alone does not count), the risk above (the largest exposure is reserve adequacy) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What does Skyward Specialty (SKWD) do?

+

Skyward Specialty Insurance Group, which markets itself as Skyward Group, underwrites commercial property and casualty insurance in specialised niches through nine US underwriting divisions: Accident & Health, Captives, Credit & Surety, Energy Solutions, Global Agriculture, Global Property, Professional Lines, Specialty Programs and Transactional E&S. Second-quarter 2026 gross written premium from those divisions was ~$667.9M. Since January 1, 2026 the company also owns Apollo, a Lloyd's of London group that underwrites through Syndicates 1969 and 1971 and provides managing agency services to nine syndicates in total. Skyward is headquartered in Houston, listed on Nasdaq under SKWD since its January 2023 IPO, and its US insurance subsidiaries hold an 'A' (Excellent) financial strength rating from AM Best.

Is SKWD a good dividend stock?

+

Skyward pays no common dividend and has not declared one since its 2023 listing, so the yield is zero. Capital return runs through buybacks instead, and even those have been modest: the board authorised $50M in October 2024, raised the authorisation to $100M on July 15, 2026, and the company repurchased 223 thousand shares for ~$9.7M during the second quarter of 2026 at an average near $43.50. Treasury stock stood at 431,006 shares carried at ~$19.4M. The credit agreements funding the Apollo acquisition contain covenants that can restrict distributions and share repurchases on certain events. Retained earnings are being used to support premium growth, which is how book value per share rose 14.6% in six months to $28.55.

Why did SKWD stock drop?

+

Shares traded as low as ~$40.60 within the past 52 weeks against a high of ~$65.69, and were around $41 in late March 2026, down roughly 15% year to date at that point. Two pressures were visible. Sell-side 2026 earnings estimates drifted lower over that stretch, from about $4.57 to $4.43 per share, as specialty property and casualty pricing softened across the sector. Separately, the Apollo acquisition added ~$437M of debt and ~$471.2M of goodwill and intangibles, and the resulting interest and amortization charges widened the gap between reported EPS ($1.07 in the second quarter) and operating EPS ($1.30). The stock has since recovered, reaching ~$56.89 in August after second-quarter results beat published estimates and ~$65.44 by November 20, 2026, up ~34.6% year to date, even though third-quarter revenue missed consensus by ~10%.

Walnut is informational, not investment advice, and gives no verdict on SKWD. Analyst targets referenced here come from a November 2026 pull of published third-party research and change constantly. The share price is the last one Yahoo Finance reported on November 20, 2026. Verify current figures with your broker before acting on them.

The case for and against similar stocks